Show simple item record

dc.contributor.authorGoodyer, Matthew J
dc.contributor.authorIsmail, Jeffri R
dc.contributor.authorO'Reilly, Seamus P
dc.contributor.authorMoylan, Eugene J
dc.contributor.authorRyan, C A M
dc.contributor.authorHughes, Paul A
dc.contributor.authorO'Connor, Alan
dc.date.accessioned2016-04-18T14:41:17Zen
dc.date.available2016-04-18T14:41:17Zen
dc.date.issued2009-12-16en
dc.identifier.citationCases Journal. 2009 Dec 16;2(1):9329en
dc.identifier.urihttp://dx.doi.org/10.1186/1757-1626-2-9329en
dc.identifier.urihttp://hdl.handle.net/10147/605755en
dc.description.abstractAbstract We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).
dc.language.isoenen
dc.subjectPREGNANCYen
dc.subjectBREAST CANCERen
dc.subjectDRUG THERAPYen
dc.titleSafety of trastuzumab (Herceptin®) during pregnancy: two case reportsen
dc.language.rfc3066enen
dc.rights.holderGoodyer et al; licensee BioMed Central Ltd.en
dc.date.updated2016-04-15T16:04:12Zen
refterms.dateFOA2018-08-27T13:56:39Z
html.description.abstractAbstract We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).


Files in this item

Thumbnail
Name:
13257_2009_Article_1401.pdf
Size:
333.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record